Want to see IN:AARTIDRUGS full AI Analyst Report?
ETFs with Aarti Drugs Limited (AARTIDRUGS) Exposure
The following ETFs maintain exposure to Aarti Drugs Limited (IN:AARTIDRUGS). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
13 ETFs Hold Aarti Drugs Limited (AARTIDRUGS)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in AARTIDRUGS |
|---|---|---|---|---|---|---|
| EPI | WisdomTree India Earnings Fund | $1.78B | 0.84% | 0.02% | $271.42K | 0.06% |
| AVEE | Avantis Emerging Markets Small Cap Equity ETF | $140.69M | 0.42% | <0.01% | $10.19K | <0.01% |
| AVXC | Avantis Emerging Markets ex-China Equity ETF | $440.92M | 0.33% | <0.01% | $27.29K | <0.01% |
| DFEV | Dimensional Emerging Markets Value ETF | $2.18B | 0.43% | <0.01% | $131.72K | 0.03% |
| AVEG | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | <0.01% | $10.99K | <0.01% |
| DEXC | Dimensional Emerging Markets ex China Core Equity ETF | $276.59M | 0.43% | <0.01% | $9,389.49 | <0.01% |
| AVEM | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | <0.01% | $850.91K | 0.20% |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | <0.01% | $255.09K | 0.06% |
| GMF | SPDR S&P Emerging Asia Pacific ETF | $387.10M | 0.49% | <0.01% | $11.06K | <0.01% |
| DFAE | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | <0.01% | $213.44K | 0.05% |
| DFSE | Dimensional Emerging Markets Sustainability Core 1 ETF | $600.94M | 0.41% | <0.01% | $13.01K | <0.01% |
| AVES | Avantis Emerging Markets Value ETF | $1.48B | 0.36% | <0.01% | $12.22K | <0.01% |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | <0.01% | $79.01K | 0.02% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in AARTIDRUGS |
|---|---|---|---|---|---|---|
| EPI | 0.02% | WisdomTree India Earnings Fund | $1.78B | 0.84% | $271.42K | 0.06% |
| AVEE | <0.01% | Avantis Emerging Markets Small Cap Equity ETF | $140.69M | 0.42% | $10.19K | <0.01% |
| AVXC | <0.01% | Avantis Emerging Markets ex-China Equity ETF | $440.92M | 0.33% | $27.29K | <0.01% |
| DFEV | <0.01% | Dimensional Emerging Markets Value ETF | $2.18B | 0.43% | $131.72K | 0.03% |
| AVEG | <0.01% | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | $10.99K | <0.01% |
| DEXC | <0.01% | Dimensional Emerging Markets ex China Core Equity ETF | $276.59M | 0.43% | $9,389.49 | <0.01% |
| AVEM | <0.01% | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | $850.91K | 0.20% |
| DFEM | <0.01% | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | $255.09K | 0.06% |
| GMF | <0.01% | SPDR S&P Emerging Asia Pacific ETF | $387.10M | 0.49% | $11.06K | <0.01% |
| DFAE | <0.01% | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | $213.44K | 0.05% |
| DFSE | <0.01% | Dimensional Emerging Markets Sustainability Core 1 ETF | $600.94M | 0.41% | $13.01K | <0.01% |
| AVES | <0.01% | Avantis Emerging Markets Value ETF | $1.48B | 0.36% | $12.22K | <0.01% |
| DFAX | <0.01% | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | $79.01K | 0.02% |
Popular ETF Comparisons
AARTIDRUGS ETF Exposure FAQ
What ETFs hold Aarti Drugs Limited stock?
Aarti Drugs Limited (IN:AARTIDRUGS) is currently held by 13 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to IN:AARTIDRUGS include Avantis (AVEM), WisdomTree (EPI) and Dimensional (DFEM).
Which ETF has the largest exposure to IN:AARTIDRUGS?
The ETF with the largest exposure to IN:AARTIDRUGS is Avantis (AVEM), with approximately INR 850.91K in market value exposure.
How much IN:AARTIDRUGS stock is held by ETFs?
ETFs currently hold approximately INR 1.79M worth of Aarti Drugs Limited (IN:AARTIDRUGS) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.